Please check your internet connection and try again.
# Sompraz HP
## Overview
Sompraz HP is a combination medication containing pantoprazole, amoxicillin, and clarithromycin, used for the eradication of *Helicobacter pylori* infection.
## Primary Indications
Treatment of *H. pylori* infection in patients with peptic ulcer disease.
## Adult Dosing
The standard adult dose is one capsule (containing pantoprazole 40 mg, amoxicillin 500 mg, and clarithromycin 500 mg) twice daily for 7 to 14 days.
## Pediatric Dosing
Pediatric dosing is not established for this combination product. Dosing for individual components may vary and should be determined by a pediatrician based on weight and clinical status.
## Dose Adjustments
No specific dose adjustments are recommended for renal or hepatic impairment for this combination product. However, caution and potential dose adjustments may be necessary for individual components, especially in severe renal or hepatic dysfunction, per prescribing information for amoxicillin and clarithromycin.
## Contraindications
* Known hypersensitivity to pantoprazole, amoxicillin, clarithromycin, or any component of the formulation.
* History of penicillin-induced severe allergic reactions.
* Use in patients with a history of cholestatic jaundice/hepatic dysfunction associated with prior macrolide exposure.
* Concomitant use with cisapride, pimozide, quinidine, or lovastatin/simvastatin due to potential for serious adverse events.
## Adverse Effects
Common adverse effects include diarrhea, nausea, headache, abdominal pain, and altered taste. Serious adverse effects can include severe allergic reactions (including anaphylaxis), *Clostridioides difficile*-associated diarrhea, liver dysfunction, QT prolongation, and potential development of antimicrobial resistance.
## Key Drug Interactions
* **Pantoprazole:** May decrease the absorption of drugs requiring an acidic gastric pH (e.g., ketoconazole, itraconazole, certain HIV protease inhibitors). May interact with warfarin.
* **Amoxicillin:** May decrease the efficacy of oral contraceptives. May interact with warfarin.
* **Clarithromycin:** Potent inhibitor of CYP3A4. Significant interactions are possible with drugs metabolized by CYP3A4, including but not limited to: colchicine, certain statins (atorvastatin, lovastatin), certain calcium channel blockers, certain anticoagulants (e.g., rivaroxaban), theophylline, and sildenafil. May increase serum concentrations of digoxin. Avoid use with ergots.
## Monitoring
* Monitor for signs and symptoms of allergic reactions.
* Assess for improvement in ulcer symptoms and *H. pylori* eradication (typically via urea breath test, stool antigen test, or biopsy 4-6 weeks after completion of therapy).
* Monitor for diarrhea, especially *C. difficile*-associated diarrhea.
* Monitor liver function tests, particularly with clarithromycin.
* Assess for potential drug interactions based on concomitant medications.
## Clinical Pearls
* This combination therapy is designed for a specific duration to maximize *H. pylori* eradication rates and minimize resistance development.
* Ensure patients complete the full course of therapy as prescribed.
* Advise patients to take the medication as directed, typically with food.
* If a dose is missed, advise patients to take it as soon as remembered, but not to double the dose.
* Consider local resistance patterns when selecting *H. pylori* eradication regimens.
***
**Disclaimer:** This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information and relevant literature to ensure optimal patient care and safety. Drug information can change, and it is the responsibility of the healthcare provider to stay updated.
